Apyx Medical (APYX) Receivables Refunds (2019 - 2023)

Apyx Medical (APYX) has 5 years of Receivables Refunds data on file, last reported at $7.8 million in Q2 2023.

• For the quarter ending Q2 2023, Receivables Refunds rose 1.44% year-over-year to $7.8 million; the trailing twelve-month figure through Jun 2023 stood at $7.8 million (up 1.44% YoY), and the FY2022 full-year result was $7.5 million, down 1.27% from the prior year.
• Receivables Refunds for Q2 2023 stood at $7.8 million, roughly flat from $7.8 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $7.8 million in Q1 2023 and bottomed at $426000.0 in Q4 2019.
• The 5-year median for Receivables Refunds is $7.6 million (2021), against an average of $6.9 million.
• The widest annual swing landed in 2020, when Receivables Refunds surged 1696.71%; it then declined 1.42% in 2022.
• A 5-year view of Receivables Refunds shows it stood at $426000.0 in 2019, then soared by 1696.71% to $7.7 million in 2020, then slipped by 0.16% to $7.6 million in 2021, then dropped by 1.27% to $7.5 million in 2022, then gained by 2.74% to $7.8 million in 2023.
• The last three Receivables Refunds figures came in at $7.8 million (Q2 2023), $7.8 million (Q1 2023), and $7.5 million (Q4 2022), per Business Quant data.

Peer Comparison